MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
common stock
$100,000
Advances from related
parties, net
$3,090
Net cash provided by
financing activities
$103,090
Stock-based compensation
expense
$277,226
Expenses allocated by
sanovas on behalf of...
$165,375
Increase in accounts
payable and accrued...
$20,947
Increase in accrued
interest
$960
Amortization of right of use
asset
$640
Net (decrease)
increase in cash
-$747
Canceled cashflow
$103,090
Total adjustments
$464,954
Canceled cashflow
$194
Net cash (used in)
operating activities
-$103,837
Canceled cashflow
$464,954
Payment of lease
liability
-$194
Net loss
-$568,791
Back
Back
Cash Flow
source: myfinsight.com
RetinalGenix Technologies Inc. (RTGN)
RetinalGenix Technologies Inc. (RTGN)